Breast Cancer
Conditions
Interventions
Sponsors
Zhejiang Chinese Medical University
Eligibility
Sex/Gender
Female
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 40-60 years, KPS score >= 60 points, WBC >= 4.0 * 10^9L-1 before treatment, normal liver and renal function, expected survival > 3 months; 2. All were pathologically confirmed breast cancer patients who met the CLINICAL practice guidelines for NCCN breast cancer (2018.v1) after modified radical mastectomy and received chemotherapy with AC regimen (adriamycin + cyclophosphamide) or TAC regimen (docetaxel + adriamycin + cyclophosphamide) for the first time. 3. It conforms to the provisions of "Standard of Curative Effect of Diagnosis of Diseases and Syndromes of Traditional Chinese Medicine" and "Guiding Principles for Clinical Research of New Chinese Medicines"; 4. All the selected patients have signed informed consent and are willing to accept the treatment of this program.
Exclusion criteria
Exclusion criteria: 1. Other complications and liver and kidney dysfunction; 2. patients receiving other traditional Chinese medicine intervention (such as taking traditional Chinese medicine, traditional Chinese medicine application, etc.);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Condition of defecation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of fecal flora and metabolites;hemanalysis; | — |
Countries
China
Contacts
Public ContactXiaohong Xu
Zhejiang Chinese Medical Universtiy
Outcome results
None listed